Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
38.85
+0.61 (1.60%)
At close: Jun 26, 2026, 4:00 PM EDT
38.50
-0.35 (-0.90%)
After-hours: Jun 26, 2026, 7:15 PM EDT
Immunovant Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Immunovant stock have an average target of 45.57, with a low estimate of 28 and a high estimate of 66. The average target predicts an increase of 17.30% from the current stock price of 38.85.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunovant stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +69.88% | May 29, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $35 → $47 | Buy | Maintains | $35 → $47 | +20.98% | May 26, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $44 → $62 | Buy | Maintains | $44 → $62 | +59.59% | May 26, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 | Buy | Reiterates | $40 | +2.96% | May 26, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $49 | Buy | Maintains | $49 | +26.13% | May 25, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
60.92M
EPS This Year
-2.44
from -2.47
EPS Next Year
-2.44
from -2.44
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | n/a | 330.3M | |
| Avg | n/a | 60.9M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2028 | 2029 |
|---|---|---|
| High | - | 1,335.8% |
| Avg | - | 565.4% |
| Low | - | -100.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | - | |
| Avg | -2.44 | -2.44 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.